• Saved
BRCA mutation carriers' perception about benefits and risks associated with combined hormonal contraceptives use

BRCA mutation carriers' perception about benefits and risks associated with combined hormonal contraceptives use

Source : https://www.tandfonline.com/doi/full/10.1080/13625187.2022.2107199?src=

Abstract To evaluate the actual perceptions about combined hormonal contraceptives (CHCs) use in BRCA mutation carriers in comparison to women from the general population. This was a cross-sectional, observational study involving two Italian referral centres for hereditary cancers.


Conclusion: Investing time and effort in transmitting the correct key messages about oncological risk related to CHC use could potentially increase their use in BRCA mutation carriers.